IVM_Vol4no3_Herceptin_hype_Page_1__83358.jpg

Herceptin hype - by Helen Lobato (IV4.3)

Regular price $2.50 Sale

Helen Lobato

looks into why the recent decision taken by the federal government

to subsidise the breast cancer drug Herceptin lacks justification.